Skip to main content

Table 8 Summary of abnormal karyotyping and PCNVS results in 71 cases

From: Application of chromosome microarray analysis in prenatal diagnosis

Prenatal diagnostic indications

Chromosome results

PCNVS results

Interpretation

VOUS results

Multiplemalformations

47,XN,+ 18

arr[hg19](18 Ɨ 3)

Ā Ā 

47,XN,+ 18

arr[hg19](18 Ɨ 3)

Ā Ā 

47,XN,+ 18

arr[hg19](18 Ɨ 3)

Ā Ā 

Abnormal karyotype of couple

46,XN,del(5p15.3)

arr[hg19]5p15.33p15.31 (113,576-9,556,461)Ɨ 1

94

Mb

arr(hg19)2p21(43,718,592-44,397,329)Ɨ3

Abnormal karyotype

46,XN,del(18)

arr[hg19]18q22.1q23(63.691,770-78,031,728)Ɨ1

14.3 Mb

arr(hg19)2p21(43,718,592-44,397,329)Ɨ 3

46,XX,15P +?

arr[hg19]Yq11.23(26,527,669-27,435,790)Ɨ0

908.1Kb

Ā 

Advanced maternal age

46XY/46,XX?

arr(X)Ɨ1ā€“2, (Y)Ɨ 0ā€“1

Ā Ā 

47,XN,+ 21

arr(21)Ɨ3

Ā Ā 

NIPT abnormal

47,XXY

arr(X)Ɨ2,(Y)Ɨ 1

Ā 

arr[hg19]22q11.23(23,652,548-25,014,592)Ɨ 3

47,XN,+ 18

arr(18)Ɨ3

Ā 

arr[hg19]1p13.3(109,341,997-109,811,502)Ɨ 3

47,XXY

arr(X)Ɨ2,(Y)Ɨ1,10q11.23q23.31(52,282,903-91,011,953)Ɨ 2 hmz

Ā 

arr[hg19]10q21.3(68,157,444-68,394,905)Ɨ1

47,XXX

arr(X)Ɨ3

Ā 

arr[hg19]Xp22.33(168,551-675,848))Ɨ0 orYp11.32(118,551-625,848)Ɨ 0

47,XN,+ 13

rr(13)Ɨ 3

Ā Ā 

47,XN,13-

?

arr[hg19]13q31.1q34(85,516,788-115,107,733)Ɨ 1

29.5 Mb

Ā 
Ā 

arr[hg19]15q11.2q13.1(23,290,787-28,644,578)Ɨ 1

5.6 Mb

Ā 

47,XXY

arr(X)Ɨ2,(Y)Ɨ 1

Ā Ā 

47,XN,+ 18

arr(18)Ɨ3

Ā Ā 

Heart malformation

Ā 

arr[hg19]22q11.21(18,648,855-21,800,471)Ɨ1

3.1 Mb

arr[hg19]Xp22.31(6,455,151-134,649)Ɨ3

Ā 

arr[hg19]16q24.3(89,349,122-89,437,985)Ɨ1

88.8Kb

arr[hg19]1q21.1(145,406,787-145,760,793)Ɨ3

47,XN,+ 18

arr(18)Ɨ3

Ā 

arr[hg19]4p15.33p15.31(12,959,345-18,763,119)Ɨ 3,21q22.12(36,372,117-37,794,593)Ɨ 1

47,XXX

arr(X)Ɨ3

Ā 

arr[hg19]22q11.21(21,029,656-21,800,471)Ɨ1

46,Xn,der(10)t(10:11)(p13;q21)

arr[hg19]10p15.3p14(100,047-10,256,448)Ɨ1,11q22.1q25(101,095,537-134,937,416)Ɨ 3

Del

10.1 Mb dup

33.8 Mb

arr[hg19]10q21.1(55,848,908-57,027,081)Ɨ3

Hydrocyst of the neck

45,X

arr(X)Ɨ1

Ā Ā 

Fetal growth restriction

Ā 

arr[hg19]4P16.3P15.32(68, 345ā€“17, 191, 595)Ɨ1

17.1 Mb

arr[hg19]5p12p11(45,288,800-46,389,261)Ɨ 3

46,XY[67%]/46,XX[33%]

arr(X)Ɨ1ā€“2,(Y)

Ā Ā 

Foot inversion

46,XN,der(18)t(2;18)(q36;18q23)

arr[hg19]2q36.1q37.3(221.954,949-242,782,258)Ɨ3,18q23(74.065,206-78,013,728)Ɨ 1

Dup

20.8 Mb

Del

l3.9Mb

Ā 

NT > 3 mm

47,XN,+ 21

arr(21)Ɨ 3

Ā 

arr[hg19]22q11.23(23,652,548-25,014,592)Ɨ 3

Nervous system abnormalities

47,XN,+ 21

arr[hg19]21q11.2q22.3(15,006,457-48,197,372)Ɨ2ā€“3

33

Mb

arr[hg19]18p11.32p11.21(136,227-12,092,218)Ɨ 2ā€“3

47,XN,+ 21

arr(21)Ɨ3

Ā 

arr[hg19]15q26.1(90,026,321-90,186,814)Ɨ 1

Ā 

arr[hg19]7q21.3q21.2(95,425,525-100,874,182)Ɨ 1

5.4 Mb

arr[hg19]6q14.1(80,827,070-80,921,191)Ɨ 1

Ā 

arr[hg19]Yq11.23(26,355,104-27,224,389)Ɨ0,16p11.2(28,708,186-29,088,624)Ɨ 1

380Kb

arr[hg19]16p13.11(15,058,820ā€“16,538,596)Ɨ3

Ā 

arr[hg19]16p11.2(28,708,186-29,032,280)Ɨ 1

324Kb

arr{hg19}2q13(110,498,141-111,369,264)Ɨ1

Ā Ā Ā 

arr[hg19]15q11.2(22,770,421ā€“23,286,423)Ɨ 1

Urinary system abnormalities

Ā 

arr[hg19]17q12(34,822,465-36,418,529)Ɨ1

1.5 Mb

arr(hg19)18q22.1(65,484,934-66,436,052)Ɨ 3

Ā 

arr[hg19]17p11.2(16,736,261ā€“20,457,631)Ɨ1

3.7 Mb

Ā 
Ā 

arr[hg19]17q12(34,822,465-36,404,555)Ɨ1

1.5 Mb

Ā 

Cleft lip and palate

Ā 

arr[hg19]15q11.2q13.1(23,290,787-28,962,791)Ɨ 1

5.3 Mb

Ā 
Ā 

arr[hg19]5p15.33p15.32(1,708,529-4,597,389)Ɨ 1,(X)Ɨ 1ā€“2,(Y)Ɨ0ā€“1

2.8 Mb

Ā 

Oligohydramnios

Ā 

arr[hg19]22q11.21(18,631,364-21,800,471)Ɨ1

3.1 Mb

Ā 

High-riskscreening

46,XN,dup(16p11.2)

arr[hg19]Yq11.23(26,527,669-27,472,434)Ɨ0,16p11.2q24.3(33,981,749-90,080,142)Ɨ 3

56

Mb

arr[hg19]Yq11.23(26,527,669-27,472,434)Ɨ0,16p11.2q24.3(33,981,749-90,080,142)Ɨ 3

Digestive disorders

Ā 

arr[hg19]15q24.1q24.2(72,930,195-75,567,135)Ɨ 1

2.6 Mb

arr[hg19]2q13q37.3(113,836,347-242,782,258)Ɨ3,22q13.2q13.33(43,689,983-51,197,766)Ɨ 1

Ā Ā Ā 

arr[hg19]Xp11.4(38,117,808-40,223,654)Ɨ2,2q13(110,498,141-110,980,295)Ɨ 3

Polyhydramnios

Ā Ā Ā 

arr[hg19]7q31.2(115,293,818-116,777,569)Ɨ 3

Ā Ā Ā 

arr[hg19]1p36.22(10,327,731-10,686,262)Ɨ1

Short nasal bone

Ā Ā Ā 

arr[hg19]12q24.33(130,475,045-132,484,803)Ɨ3

Adverse pregnancy history

Ā Ā Ā 

arr[hg19]10q21.3(68,141,036-68,551,407)Ɨ1

FISH does not match karyotype

Ā Ā Ā 

arr[hg19]10q23.31q23.32(90,101,722ā€“93,091,030)Ɨ3

Pleural effusion

Ā Ā Ā 

arr[hg19]7p21.3(11,104,500ā€“12,669,251)Ɨ3,18q11.2(20,490,086-20,637,568)Ɨ1

Ā Ā Ā 

arr[hg19]1q43(241,281,153-241,882,720)Ɨ3

Ā Ā Ā 

arr(hg19)2p21(43,718,592-44,397,329)Ɨ3

Total

23

17

Ā 

31

  1. In each case, karyotype analysis and CMA testing were performed simultaneously. Aneuploidy, abnormal structural abnormalities and chimeras detected by chromosome and CMA were classified as chromosomal abnormalities. Only microdeletions and microduplications detected by CMA were classified as pathogenic copy number variations
  2. Some karyotypes are written with XN (where N = X or Y), as sex of the fetus was not disclosed on prenatal reports
  3. PCNVs Pathogenic copy number variations, VOUS Variant of uncertain significance